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Abstract
There has been considerable interest in urethral‐sparing cystectomy and preservation of the 
gynecological tract to maintain continence mechanism, sexual function, and reproductive 
function in young patients who undergo radical cystectomy for muscle‐invasive bladder 
cancer and this new technique gained acceptance in many centers. The issue of oncological 
safety of a urethra and anterior vaginal wall‐sparing cystectomy in selected patients has been 
addressed by several authors. The chapter will discuss the following items: (I) Technique of 
genital‐sparing radical cystectomy in female patients with muscle invasive transitional cell 
carcinoma of the bladder. (II) Definition and rationale of genital‐sparing radical cystectomy 
in female patients. (III) Rational and value of urethral preservation in genital‐sparing cys‐
tectomy in female patients with urothelial carcinoma. (IV) Previous reports about genital‐
sparing cystectomy in patients with urothelial carcinoma. (V) Value of preservation of the 
internal genital organs in female patients undergoing radical cystectomy.
Keywords: genital‐sparing, radical cystectomy, female, transitional cell carcinoma, 
urinary diversion
1. Introduction
Radical cystectomy in females includes an anterior exenteration, i.e., removal of the blad‐
der, urethra, uterus, fallopian tubes, ovaries, and anterior wall of the vagina. The oncological 
necessity for removal of the internal genital organs has been questioned [1].
There has been considerable interest in urethral‐sparing cystectomy and preservation of the 
gynecological tract to maintain continence mechanism, sexual function, and reproductive 
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function in young patients who undergo radical cystectomy for muscle‐invasive bladder can‐
cer and gained acceptance in many centers [2–5].
The issue of oncological safety of a urethra and anterior vaginal wall‐sparing cystectomy in 
selected patients has been addressed by several authors [2–7].
The scientific rationale of internal genital organ preservation during radical cystectomy in 
women was based on studies documented the low incidence of internal genitalia involvement 
in female bladder cancer [4–7].
With increasing survival from bladder cancer, quality of life (QOL) and quality of sexual‐
ity considered now an important end point after such type of surgery particularly in young 
female patients diagnosed with bladder cancer and eager to preserve fertility [4, 5].
Studies concerning genital‐sparing cystectomy are few and their limitations included; few 
cases [4–6], retrospective [8, 9], limited long‐term follow‐up [4, 5, 7], incomplete functional and 
oncological outcome [6, 7], and finally included cases with nonorthotopic diversion [5–7, 10].
2. Technique of genital‐sparing radical cystectomy in female patients 
with muscle invasive transitional cell carcinoma of the bladder
2.1. Preoperative assessment
History taking included; voiding and sexual function questionnaire while staging of the 
tumor included; clinical examination for clinical staging of the tumor and investigation like 
pelvic‐abdominal ultrasound and CT scanning.
A thorough gynecological checkup includes a vaginal pap smear and transvaginal ultra‐
sound. Cystoscopy was done (with biopsy from the tumor itself, bladder neck, trigone, and 
posterior wall) to exclude carcinoma in situ (CIS). Sexual function was assessed through spe‐
cific questions about sexual desire (libido), orgasmic problems, and dyspareunia. Continence 
was assessed through voiding diary and reporting day and night continence and voiding 
frequency.
2.2. Preoperative preparation
Bowel preparation is started one day before the operation and consisted of two colonic return 
flow‐enemas. All patients received prophylactic antibiotics (cephalosporin and metronida‐
zole) 1 hour before operation and SC heparin the morning of the operation with medical leg 
stocking immediately preoperative.
2.3. Position and anethesia and incision
Bilateral leg compression stocking are applied.
The patient is placed in dorsal Trendelenburg position with overextension of the pelvis to 
open the area between the umbilicus and the pelvis.
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The preferred types of anesthesia are either general anesthesia or combined general and epi‐
dural anesthesia. A 20 French Foley catheter is introduced in the urethra and the balloon 
inflated to 20 cc. Sponge is introduced in the vagina. A lower midline subumbilical incision 
is made.
2.4. Lymphadenectomy
Bilateral pelvic lymphadenectomy is performed from the site of crossing of the ureter over the 
common iliac artery (proximally) to the lateral circumflex iliac vein, inguinal ligament, and 
node of Cloquet (distally) and from the genitofemoral nerve crossing the psoas muscle (later‐
ally) to the bladder (medially) and including the hypogastric, presciatic, presacral, and obtu‐
rator fossa nodes. If we found grossly palpable and suspicious node, we extend the margins of 
lymphadenectomy till paraaortic lymph nodes and consider abandoning the genital‐sparing 
technique to standard.
2.5. Posterior dissection
Transverse or U‐shaped incision is made in the peritoneum of the Cul‐de‐sac between the 
bladder and the uterus (Figure 1).
Dissecting the fatty and fibrovascular tissue between the uterus and the bladder as far inferi‐
orly as the level of the cervix will be the next step (Figure 2).
The ureter is dissected from the iliac bifurcation proximally to the posterior bladder wall dis‐
tally (juxtavesical ureter) where it is crossed by the uterine artery, which is preserved.
The ureters are clipped and transected, cut margins are sent for frozen section examination 
(Figure 3).
Lateral vesical pedicles are secured and divided. While dissecting lateral to the bladder, it is 
advisable to avoid injury to paravaginal tissues so that the branches of the pelvic nerve plexus 
Uterus
Bladder
Figure 1. Urachus is divided, transverse or U‐shaped incision is made in the peritoneum of the Cul‐de‐Sac between the 
bladder and the uterus.
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(which course laterally to the vagina) can be preserved. Cardinal ligaments (connecting lateral 
surface of the cervix and the vagina to the pelvic wall) left intact.
2.6. Anterior dissection
Endopelvic fascia is incised close to the bladder neck, then we identify the vesico‐urethral 
junction (bladder neck) by slight traction on the balloon,and putting  two small sponge sticks 
(peanuts) on either side of the balloon (Figure 4).
Figure 2. Dissecting the fatty and fibrovascular tissue between the uterus and the bladder as far inferiorly as possible 
(level of the cervix).
Uterus
Bladder
Left Ureter
Right Ureter
Figure 3. The ureter is dissected from the iliac bifurcation proximally to the posterior bladder wall distally (juxtavesical 
ureter), clipped and transected, cut margins are sent for frozen section examination.
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The dorsal venous complex is ligated and divided. Ligation of the dorsal vein complex in 
female patients differs from male patients where other options are available to manage.
By sharp dissection, the urethra is dissected from its attachments to the vagina 0.5 cm below 
the bladder neck and is hooked with a right angle clamp.
Urethra
Urethral cath.
Bladder
Urethral cath.
Urethral cath.
Bladder
Urethral cath.
Bladder
(a)
(b) (c)
(d) (e)
Figure 4. Endopelvic fascia incised close to the bladder neck, identify the vesicourethral junction (bladder neck). The 
dorsal venous complex is ligated and divided, the urethra is dissected from its attachments to the vagina and is hooked 
with a right angle clamp. The anterior wall of the urethra is divided sharply, the catheter pulled out, clamped proximally 
to prevent balloon deflation, and divided and then the posterior wall is divided. Urethral cut margins are sent for frozen 
section examinations.
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The anterior wall of the urethra is divided sharply 0.5 cm below the bladder neck, the catheter 
pulled out, clamped proximally to prevent balloon deflation, and divided and then the poste‐
rior wall is divided with care to avoid injury of the vaginal wall.
Urethral cut margins are sent for frozen section examinations.
Care is taken not to dissect anterior and distal to the level of the transection, to ensure pres‐
ervation of the pubourethral and urethropelvic ligaments, and to decrease the possibility of 
vaginal wall descent and pelvic prolapse.
2.7. Developing vesicovaginal and vesicourethral space
This is the most difficult and bloody part of the operation.
By gentle traction on the catheter, the bladder neck is dissected off the vaginal vault, sharp 
and blunt dissection continued upwards between the bladder and the vagina to connect with 
the previously developed posterior plane carefully without injuring the vault of the vagina 
and paravaginal tissues (Figure 5).
Six sutures of 3‐0 vicryl are placed in the distal cut end of the urethra and retained for later 
anastomosis to the neobladder (Figure 6).
Alternatively, the vesicovaginal space can be developed in antegrade manner starting from above 
at the level of the junction between the cervix and the anterior vagina (whitish plane) (Figure 7).
Bladder
Uterus
Vagina
Urethra
Urethral cath.
Figure 5. By gentle traction on the catheter, the bladder neck is dissected off the vaginal vault, sharp and blunt dissection 
continued upwards between the bladder and the vagina to connect with the previously developed posterior plane 
carefully.
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Uterus
Vagina
Cervix
Uterus
Vagina
Urethra
(a)
(b)
Figure 6. (a) Final picture after removal of the bladder and (b) six sutures of 3‐0 vicryl are placed in the distal cut end of 
the urethra and retained for later anastomosis to the neobladder.
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Dissection close to the vaginal wall will avoid injury to the neurovascular bundles supplying 
vagina, urethra, and clitoris.
2.8. Urinary diversion
A segment of 60 cm of the ileum is isolated on a vascular pedicle from a point 15–20 cm proxi‐
mal to the ileocaecal junction. The bowel is detubularized and reconfigured in a W pouch.
The ureters are implanted creating serosa‐lined tunnels.
The neobladder is anastomosed to the urethra using the preplaced vicryl sutures over a 20‐
French Foley catheter (Figure 8). The anastomotic site must sit broadly on the pelvic floor and 
should be away from the most dependent part of the reservoir. In one patient, an ileocaecal 
neobladder was created.
It is not essential to use a well‐vascularized omental flap behind the reconstructed pouch in 
our cases because the preserved vagina was not opened (no suture lines).
The initial capacity was assessed by filling the bladder through the Foley catheter, and the 
initial capacity was approximately 120 cc after filling.
Two ureteral stents were left.
Drains are placed and the incision is closed in layers.
2.9. Postoperative care and follow up
Ureteral stent is removed 7–9 days postoperatively before discharge.
Urethral catheter is removed 2 weeks postoperatively if the pouchogram showed no 
extravasations.
Pouch wash with sodium bicarbonate starting from the 4th day postoperatively. Patient is 
advised to void by pelvic floor relaxation in sitting position at 3‐hour interval day and night, 
Bladder
Uterus
Vagina 
Figure 7. Alternatively, the vesicovaginal space can be developed in antegrade manner starting from above at the level 
of the junction between the cervix and the anterior vagina (whitish plane).
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increase the voiding intervals gradually with time (retain urine for 3–4 hours) to obtain blad‐
der capacity of 500 cc.
Patient sexual function, voiding patterns, and continence are assessed by means of a validated 
questionnaire and personal interviews. Sexual function was assessed through specific questions 
about sexual desire (libido), orgasmic problems, and dyspareunia. Continence was assessed 
through voiding diary and reporting day and night continence and voiding frequency.
The patient is considered to be continent if she required not more than one pad during the 
night or the day. Postvoid residual urine is assessed by means of ultrasound or self‐catheter‐
ization after spontaneous voiding.
Pathological examination of the specimen is done to assess the stage, grade, and lymph node 
status.
Follow up at 3‐month interval should include: personal interviews (sexual function with 
three questions related to dyspareunia, vaginal lubrication and overall satisfaction), voiding 
patterns, continence (number of pads used), chemistry, gynecological examination, test for 
residual urine, and CT examination.
3. Definition and rationale of genital‐sparing radical cystectomy in 
female patients
In the past, radical cystectomy in females included an anterior exenteration, i.e., removal of the 
bladder, urethra, uterus, fallopian tubes, ovaries, and anterior wall of the vagina. The reasons 
for removing the adnexa (in radical cystectomy in female patients) are not clear and have been 
questioned because bladder cancer rarely extends to these organs. The risk of internal genitalia 
Figure 8. The final picture after fishing closure of the orthotopic pouch with poucho‐urethral anastomosis.
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involvement in female cystectomy specimen was reported to be low whether primary or sec‐
ondary. Uterine involvement in patients with urothelial cancer has been reported in 1/37 and in 
2/40 radical cystectomy specimens in Groutz et al. and Chang et al. studies, respectively [11, 12].
In another study included more than 600, the rate of concomitant gynecological organ involve‐
ment has been reported to be 2.6% [13].
In our previous studies, we examined cystectomy specimens from 360 consecutive female 
patients with bladder cancer, pathologically for internal genitalia involvement. Uterine involve‐
ment was observed in one case of TCC (pT4, grade III). Uterine benign pathology was detected 
in 25 cases. All patients had normal ovaries regardless of tumor site or stage while the vagina was 
involved in 11 cases. Ten percent of the patients had urethral involvement (all had TCC). During 
late follow up of 50 patients (included two cases with uterine preservation, and in all cases, at 
least one ovary was preserved), no single ovarian or uterine recurrence was reported [14, 15].
4. Rational and value of urethral preservation in genital‐sparing 
cystectomy in female patients with urothelial carcinoma
Urethral preservation under specific criteria of tumor site and extension is quite safe and 
facilitates orthotopic reconstruction with spontaneous voiding and improves the quality of 
life in such patients [16, 17]. Pathological studies in female radical cystectomy specimens have 
demonstrated that the urethra is rarely involved in the absence of bladder‐neck involvement 
[18] or extensive carcinoma in situ [19]. Preservation of the distal part of the urethral will allow 
reconstruction of new bladder from the small intestine to be anastomosed to the preserved 
urethra. Follow up of those patients proved the safety of urethral preservation. This option 
will definitely increase the acceptance by the patients to do such type of surgery and also will 
increase its practice among urosurgeons [18–20].
5. Previous reports about genital‐sparing cystectomy in patients with 
urothelial carcinoma
Preservation of the sexual function in women has not been the main goal in most studies of 
neobladder in women and studies concerning genital‐sparing cystectomy are lacking. Only 
four series were reported addressing this issue; one series of open surgery in three cases of TCC 
[4], one series of robotic surgery in two cases of TCC [6], one series of laparoscopic surgery in 
one case of TCC [5], and one series of laparoscopic surgery in 13 cases of neurogenic vesical 
dysfunction [7]. The number of cases in these studies is limited; the follow up was very short 
and no report was mentioned on the oncological function in terms of local recurrence  (Table 1).
Horenblas et al. [4] reported on sexuality preserving cystectomy in three female patients with 
bladder cancer, using a retrograde method. No patient had a local recurrence, and daytime 
and nighttime continence was reported in 66% of cases while the remainder needed intermit‐
tent catheterization. One patient developed a vaginal urinary fistula and was converted to 
Bladder Cancer - Management of NMI and Muscle-Invasive Cancer120
Reference Horenblas  
et al. [4]
Menon et al. [6] Game et al. [7] Moinzadeh et al. [5] Kulkarni et al. [8] Koie et al. [9] Salem [10]
Year 2001 2004 2007 2005 2008 2009 2008
Country Netherlands USA France USA India Japan Egypt
Pathology TCC* TCC Neurogenic 
vesical 
dysfunction
TCC TCC 29: TCC
1: leiomyosarcoma
TCC
No. of cases 3 3 13 11 14 (retrospective) 30 (retrospective) 20
Genital‐sparing cases 3 2 13 1 14 30 20
Technique Open Robotic Laparoscopy Laparoscopy Open Open Open
Diversion Orthotopic Ileal conduit,  
W pouch,  
T pouch
Noncontinent 
trans ileal Bricker
Ileal conduit (8), 
Studer (2), Indiana 
pouch (1)
Neobladder Neobladder 
(U‐shaped)
W pouch (24), Le 
Bag (1)
Mean op. time (min.) − 160 (cystectomy)
130 (ileal conduit)
180 (orthotopic)
325 ± 36 510 320 301 210 ± 35
Mean hospital stay − 6.7 11.6 ± 1.9 6 − − 11 ± 3
Mean follow‐up 
(months)
3.5 − 7.4 ± 5.4 7.1 32.5 35.7 70
Daytime continence 66% − Excellent 7 24 70%
Nighttime continence 66% − − Excellent 7 24 85%
Hypercontinence 
(intermittent 
catheterization)
33% − − −ve 4 0 15%
Local recurrence −ve − − − 1 1 0%
Mean blood loss (cc) − 100 343.1 ± 246.3 − 300–1500 983 300 ± 120
Table 1. Showing previous reports on genital‐sparing cystectomy.
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a continent catheterizable stoma. Vaginal lubrication and orgasmic feeling were reported to 
be normal after surgery.
Menon et al. [6] reported robotic‐assisted radical cystectomy in three female patients, one of 
them was anterior exenteration and two of them genital‐sparing cystectomy. No report was 
mentioned on the mean follow up, continence, or local recurrence.
In our previous study, we excluded the pathology of the internal genitalia by standard clinical 
and gynecological examination. To decrease the risk of subsequent local recurrence, we excluded 
patients with tumor at the trigone, posterior wall, bladder neck, and associated carcinoma in 
situ. For greater safety, we did intraoperative frozen section biopsy of the urethral surgical mar‐
gin. The surgical margins were free in all patients (urethral margin, posterior bladder wall). 
Only in one case, there was microscopic invasion of the anterior wall (pT3a III TCC). At the last 
follow up, all patients are alive and well with no evidence of disease recurrence. None of these 
had urethral or vaginal recurrences. Seventeen (85%) patients voided spontaneously. Fourteen 
(70%) of them were continent day and night and three of them suffering from some form of urge 
or stress incontinence in the first 3 months after surgery. The remaining three patients (15%) 
needed regular self‐catheterization (hyper continent). Median bladder capacity at the last follow 
up was 450 cc (350–600). Median residual urine was 100 cc (0–350). All patients were sexually 
active 3 months after surgery. Vaginal lubrication was reported in 16 patients. Two patients were 
suffering from dyspareunia. Orgasmic function was preserved in 16 patients [10].
6. Value of preservation of the internal genital organs in female patients 
undergoing radical cystectomy
There is no doubt that removal of the internal genitalia in premenopausal women will affect 
the quality of life of such patient and will cause psychological trauma especially in young 
patients eager to have children. With increasing survival from urologic cancer, quality of life, 
and quality of sexuality should be one of the main goals following radical cystectomy in 
female patients with bladder cancer. Hence, routine removal of the internal genitalia has to 
be investigated thoroughly.
Preservation of the internal gynecological organs will improve the functional outcome and 
will have positive impact on the quality of life after exclusion of concomitant primary or sec‐
ondary gynecological malignancy by careful preoperative assessment.
6.1. The vagina
The preserved vagina will provide backing to the neobladder, prevent pouchocele formation 
in the dead space, provide better support to the distal urethra to prevent kinking of the ureth‐
ropouch anastomosis decreasing the likelihood of hyper continence, and maintain the sexual 
function in women who want it particularly if nerve‐sparing technique was done and vaginal 
lubrication was preserved. No chance of fistula formation between the vagina and the new 
pouch because there is no suture line in the preserved vagina.
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In patients with urothelial carcinoma away from the bladder base or the bladder neck (dome 
and anterior wall tumors), the anterior vaginal wall may be preserved [21]. The oncological 
safety of preservation of the anterior vaginal wall has been proved in another study by Chen 
et al. in 1996 in a retrospective study at MD Anderson Cancer Center [22].
6.2. The uterus
The uterus will retain the reproductive function in this group of patients, in addition, the 
uterus will prevent vaginal vault or pelvic prolapse. Chang et al. [23] suggested that preser‐
vation of uterus and its supports may prevent the dead space that otherwise would be filled 
by small bowel which in some may produce anterior enterocele following cystectomy as was 
reported by Anderson et al. [24]. The uterus also plays a role in orgasmic function [25].
Removal of the uterus may be associated with psychological trauma in young sexually active 
women eager to have a child when future pregnancy is contemplated.
We believe that in postmenopausal women or in those who no longer desire future fertility, 
hysterectomy seems a reasonable adjunct to cystectomy.
6.3. The ovaries
Data concerning metastasis of bladder TCC to the ovaries are scarce and autopsy studies 
showed that ovarian metastasis due to TCC of the bladder ranged between 0 and 9% [26–29]. 
Marshall and Treiger suggested one ovary to be left to preserve the hormonal function after 
radical cystectomy [30], acute premature menopause (ovarian hormone deprivation) is asso‐
ciated with increased menopausal symptoms, ischemic heart disease, and osteoporosis risk. 
Prolonged hormone replacement therapy used to alleviate symptoms and minimize these 
risks has been associated with increased incidence of breast cancer especially if used for more 
than 5 years [31].
The criteria for patients selection for genital sparing include the following: single monofocal 
localized tumor, away from the bladder neck, trigone or posterior wall, no associated carci‐
noma in situ, patient with serum creatinine of less than 1.7 mg/dl, patient agree and able to 
perform self‐catheterization, patient motivated for preservation of sexual function (sexually 
active), and no cervical or uterine abnormalities.
7. Conclusion
Here, we have described a technique of genital‐sparing radical cystectomy with orthotopic neo‐
bladder in selected female patients. The technique is feasible and of low morbidity with reason‐
able oncological and functional outcome. Although radical cystectomy is the gold standard for 
female patients with bladder cancer, preservation of the internal genitalia in young sexually active 
women eager to have children should be considered in selected cases under strict criteria. The 
desire to achieve functional good results should not violate the oncological surgical principles.
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